SHANGHAI PHARMACEUTICALS HOLDING CO financial statements, including revenue, expenses, and profit
The total revenue of 2607 for the last quarter is 70.77 B HKD, and it's 7.12% lower compared to the previous quarter. The net income of Q4 24 is 538.93 M HKD.